In a significant breakthrough, researchers from La Trobe University have developed an artificial intelligence (AI) tool that could revolutionise the way stage-two bowel cancer patients are treated. The new technology, dubbed SÉMIL (Semantically-Enhanced Multiple Instance Learning), has the potential to identify those at a higher risk of relapse, allowing for earlier and more targeted interventions. [...]
New AI tool could help predict bowel cancer relapse risk
